All Stories

  1. HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon

    Article • PLoS ONE, September 2024, PLOS

    Christian Mangala, Dr Joseph Fokam

  2. Evaluation of plasma viral-load monitoring and the prevention of mother-to-child transmission of HIV-1 in three health facilities of the Littoral region of Cameroon

    Article • PLoS ONE, November 2022, PLOS

    Dr Joseph Fokam

  3. HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis

    Article • PLOS Global Public Health, October 2022, PLOS

    Dr Joseph Fokam

  4. Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)

    Article • PLoS ONE, September 2022, PLOS

    Dr Joseph Fokam

  5. Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol

    Article • PLoS ONE, August 2022, PLOS

    Dr Joseph Fokam

  6. Anti-Toxoplasmic Immunoglobulin G Quantitation Correlates with Immunovirological Parameters of HIV-Infected Cameroonians

    Article • Current HIV Research, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr Joseph Fokam

  7. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon

    Article • PLoS ONE, July 2020, PLOS

    Dr Joseph Fokam

  8. Pretreatment HIV Drug Resistance in Cameroon

    Article • AIDS Research and Human Retroviruses, April 2016, Mary Ann Liebert Inc

    Dr Joseph Fokam

  9. The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring

    Article • International Journal of Mycobacteriology, March 2016, Elsevier

    Dr Joseph Fokam

  10. High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians

    Article • Current HIV Research, February 2016, Bentham Science Publishers

    Dr Joseph Fokam

  11. Phylogenetics of HIV-1 subtype G env: Greater complexity and older origins than previously reported

    Article • Infection Genetics and Evolution, October 2015, Elsevier

    Dr Joseph Fokam

  12. The Public Health perspective on Migratory Health – Displaced Populations in Global Disease Epidemics

    Article • June 2015, IntechOpen

    Dr Joseph Fokam

  13. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations

    Article • PLoS ONE, June 2015, PLOS

    Dr Joseph Fokam

  14. HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon

    Article • Current HIV Research, June 2015, Bentham Science Publishers

    Dr Joseph Fokam

  15. Current practice of epidemiology in Africa: highlights of the 3rd conference of the African epidemiological association and 1st conference of the Cameroon society of epidemiology, Yaoundé, Cameroon, 2014

    Article • Pan African Medical Journal, January 2015, Pan African Medical Journal

    Dr Joseph Fokam, Kingsley Akinroye

  16. Distribution épidémiologique de l’infection à VIH chez les femmes enceintes dans les dix régions du Cameroun et implications stratégiques pour les programmes de prévention

    Article • Pan African Medical Journal, January 2015, Pan African Medical Journal

    Dr Joseph Fokam

  17. Co-Infection of Hepatitis B Virus and Hepatitis Delta Virus in Yaounde-Cameroon

    Article • British Microbiology Research Journal, January 2014, Sciencedomain International

    Dr Joseph Fokam

  18. Prevalence of HIV, HBV and chlamydia infections in Cameroonian University context: case of the University of Dschang, in the Western region

    Article • BMC Infectious Diseases, January 2014, Springer Science + Business Media

    Dr Joseph Fokam

  19. Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance

    Article • PLoS ONE, August 2013, PLOS

    Dr Joseph Fokam

  20. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008–2010: lessons and challenges for low-resource settings

    Article • BMC Public Health, January 2013, Springer Science + Business Media

    Dr Joseph Fokam

  21. Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010

    Article • PLoS ONE, May 2012, PLOS

    Dr Joseph Fokam

  22. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon

    Article • Journal of Medical Virology, March 2012, Wiley

    Dr Joseph Fokam

  23. Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

    Article • The Pediatric Infectious Disease Journal, December 2011, Wolters Kluwer Health

    Dr Joseph Fokam

  24. 197 Population Level Drug Resistance Mutations in HIV Type 1 Protease and Reverse Transcriptase in Cameroon: 1995 to 2010 Review

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

    Dr Joseph Fokam